Elizabeth Jean Degroff, PT, DPT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2841 Thousand Acres Rd, Delanson, NY 12053 Phone: 518-875-6141 |
Samantha Jean-dibbell Smith Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2841 Thousand Acres Rd, Delanson, NY 12053 Phone: 518-857-6141 |
Kathleen Sellnow, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2841 Thousand Acres Rd, Delanson, NY 12053 Phone: 518-875-6141 |
Donna Puiatti, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2841 Thousand Acres Rd, Delanson, NY 12053 Phone: 518-875-6724 |
Marjane Brannen Selleck, PT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 499 E Shore Rd, Delanson, NY 12053 Phone: 518-339-6880 |
News Archive
Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac was selected by China Business Media as one of China's Top 10 most competitive companies listed overseas for 2009.
DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.
Mallinckrodt plc, a leading specialty biopharmaceutical company, announced today that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been treated in the first of two pivotal trials of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation occurring in about 50 percent of melanomas and about eight percent of all solid tumors.
Patients with unruptured brain aneurysms have significant reductions in several areas of quality of life—especially physical functioning, reports a study in the April issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
› Verified 5 days ago